Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma

Oncology

Volumn 77, Issue 3-4, 2009, Pages 178-181

  Park, Chul Kee ^a   Jung, Ji Hye ^a   Moon, Min Jeong ^a   Kim, Young Yim ^a   Kim, Jin Hyun ^b   Park, Sung Hye ^a   Kim, Chae Yong ^a   Paek, Sun Ha ^a   Kim, Dong Gyu ^a   Jung, Hee Won ^a   Cho, Byung Kyu ^a  

^a Seoul National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Glioblastoma; Long term survival; Manganese superoxide dismutase; Prognostic factor; Proteomics

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; AGED; BRAIN NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPEROXIDE DISMUTASE;

EID: 67651210374     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231888     Document Type: Article

References (11)

1. Senger D, Cairncross JG, Forsyth PA: Longterm survivors of glioblastoma: Statistical aberration or important unrecognized molecular subtype? Cancer J 2003; 9: 214-221.
2. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G: Long-term survival with glioblastoma multiforme. Brain 2007; 130: 2596-2606.
3. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD: Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res 2002; 8: 180-187.
4. Kraus JA, Wenghoefer M, Glesmann N, Mohr S, Beck M, Schmidt MC, Schröder R, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Heuser K, Müller B, Fimmers R, von Deimling A, Schlegel U: TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (Apo- 1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme. J Neurooncol 2001; 52: 263-272.
5. Park CK, Kim JH, Moon MJ, Jung JH, Lim SY, Park SH, Kim JH, Kim DG, Jung HW, Cho BK, Paek SH: Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression. J Cancer Res Clin Oncol 2008; 134: 255-262.
6. Weisiger RA, Fridovich I: Superoxide dismutase. Organelle specificity. J Biol Chem 1973; 248: 3582-3592.
7. Zhong W, Oberley LW, Oberley TD, St Clair DK: Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 1997; 14: 481-490.
8. Lam EW, Zwacka R, Seftor EA, Nieva DR, Davidson BL, Engelhardt JF, Hendrix MJ, Oberley LW: Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells. Free Radic Biol Med 1999; 27: 572-579.
9. Ria F, Landriscina M, Remiddi F, Rosselli R, Iacoangeli M, Scerrati M, Pani G, Borrello S, Galeotti T: The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. Br J Cancer 2001; 84: 529-534.
10. Freeman BA, Crapo JD: Biology of disease: free radicals and tissue injury. Lab Invest 1982; 47: 412-426.
11. Shatrov VA, Ameyar M, Bouquet C, Cai Z, Stancou R, Haddada H, Chouaib S: Adenovirus- mediated wild-type p53 gene expression sensitizes TNF-resistant tumor cells to TNFinduced cytotoxicity by altering the cellular redox state. Int J Cancer 2000; 85: 93-97.